Skip To Main Content
Barney S. Graham on Muck Rack

Barney S. Graham

As seen in: The New York Times, British Journal of Cancer, Nature, JAMA: Journal of the American Medical Association, Medscape, Science Magazine, The Atlanta Journal-Constitution, Cell Reports, The Lancet, Cell Press and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Barney S.

Contact Barney S., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Full-length premembrane protein is not required for mature Zika virus particle assembly

|
By Kimberly A. Dowd, Huaxin Song, Saif Malik, Egan Sanchez, Beniah Brumbaugh, Bryant M. Foreman, Katherine E. Burgomaster, Wei Shi, Lingshu Wang, Natalie Caputo, David Gordon, Cindi L. Schwartz, Bryan Hansen, Adam S. Olia, Mehin Suleiman, Jessica Guyette, Maya Aleshnick, Wing-Pui Kong, Kaitlyn M. Morabito, Yaroslav Tsybovsky, Heather D. Hickman, Barney S. Graham, Elizabeth Fischer, Tongqing Zhou
| Science Magazine Verified
Editor’s summary Abstract Supplementary Materials REFERENCES AND NOTES Information & Authors Metrics & Citations Check Access References Figures Tables Media Share Editor’s summary Proteolytic cleavage of the structural premembrane (prM) protein of flaviviruses such as Zika virus is seen as a defining step in virus particle maturation. Dowd et al. now show that Zika virus particles can assemble without the pr domain of prM, challenging established models of flavivirus generation.
Open in Who Shared Issue with article?

A structure-based mRNA vaccine for Nipah virus in healthy adults: a phase 1 trial

|
By Aurélie Ploquin, Rosemarie Mason, Myra Happe, Alicia Widge, Laura Novik, Ana M. Ortega-Villa, Galina V. Yamshchikov, Ingelise Gordon, Abidemi Ola, Anita Arthur, Floreliz Mendoza, Jamie Saunders, William Whalen, Joanna Utoh, Jennifer Cunningham Verified, Lorin N. Loftus, Ashley Heimann, Katia G. Korzeniwsky, Shayne F. Andrew, Evan R. Lamb, Amelia Thompson, Mary McDonald, Kathryn E. Foulds, Nancy Sullivan, Emily Coates, Rebecca J. Loomis, Barney S. Graham, Karin Bok, Sunny Himansu, Brett Leav, John H Beigel, Mario Roederer, Lesia Dropulic, LaSonji A. Holman, Pamela J. M. Costner, Xioalin Wang, Shruthi Shyam Sunder, Jessica Bahorich, Walla Dempsey
| Nature Verified
Abstract Nipah virus (NiV) is a highly pathogenic, zoonotic paramyxovirus with pandemic potential. No licensed vaccines or treatments are available. Therefore, we conducted a phase 1, first-in-human, open-label, dose-escalation trial of a lipid nanoparticle mRNA vaccine, mRNA-1215, encoding a chimeric pre-fusion F (Pre-F) protein linked to glycoprotein G of a NiV Malaysian strain.
Open in Who Shared Issue with article?

Modulating the immunodominance hierarchy of immunoglobulin germline-encoded structural motifs targeting the influenza hemagglutinin stem

|
By Sila Ataca, Maya Sangesland, Larance Ronsard, Seyhan Boyoglu-Barnum, Rebecca A. Gillespie, Yaroslav Tsybovsky, Tyler Stephens, Syed M. Moin, Julia Lederhofer, Adrian Creanga, Sarah Andrews, Ralston M. Barnes, Daniel Rohrer, Nils Lonberg, Barney S. Graham, Andrew Ward, Daniel Lingwood, Masaru Kanekiyo
| Cell Reports Verified
Keywords influenza virus broadly neutralizing antibody bnAb hemagglutinin germline-targeting HA stem nanoparticle B cell IGHV1-69 IGHD3-9 Research topic(s) CP: Immunology Introduction Influenza A and B viruses cause seasonal epidemics and hundreds of thousands of hospitalizations and deaths every year.1 Influenza A viruses (IAVs) have also been responsible for four major global pandemics in the last 110 years.
Open in Who Shared Issue with article?
See all 24 licensed articles (25 Total)